(Q41629073)

5 October 2017

title

Role of epithelial-mesenchymal transition markers in triple-negative breast cancer (English)

1 reference

5 October 2017

Sai Yin Cheung

1

1 reference

5 October 2017

Yvonne Jia Yu Boey

2

1 reference

5 October 2017

Valerie Cui Yun Koh

3

1 reference

5 October 2017

Aye Aye Thike

4

1 reference

5 October 2017

Jeffrey Chun Tatt Lim

5

1 reference

5 October 2017

Jabed Iqbal

6

1 reference

5 October 2017

Puay Hoon Tan

7

1 reference

5 October 2017

language of work or name

English

0 references

publication date

30 June 2015

1 reference

Breast Cancer Research and Treatment

5 October 2017

published in

1 reference

5 October 2017

volume

152

1 reference

5 October 2017

issue

3

1 reference

5 October 2017

page(s)

489-498

1 reference

Global estimates of cancer prevalence for 27 sites in the adult population in 2008.

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Triple-negative breast cancer: epidemiology and management options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

The treatment and survival of patients with triple negative breast cancer in a London population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Triple negative tumours: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Gene of the month: E-cadherin (CDH1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Significance of E-cadherin expression in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Multifactorial regulation of E-cadherin expression: an integrative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Noncanonical TGF-β signaling during mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Occurrence and significance of epithelial-mesenchymal transition in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Breast cancer stem cells: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

TGF-β: duality of function between tumor prevention and carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

E-Cadherin as a diagnostic biomarker in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the SEER Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

TGFβ and matrix-regulated epithelial to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Heterogeneity in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3485-1

10.1007/S10549-015-3485-1

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

5 October 2017

1010977567

0 references

1 reference